Detailed price information for Transcode Therapeutics Inc (RNAZ-Q) from The Globe and Mail including charting and trades.

TransCode Therapeutics ( (RNAZ)) has provided an update. On February 5, 2026, TransCode Therapeutics, in collaboration with Quantum Leap Healthcare Collaborative, announced that it had submitted an ...

TransCode reports no dose-limiting toxicities, durable disease stabilization in metastatic patients; advances to Phase 2 development in ctDNA-positive cancers using next-generation RNA therapeutics.

Live Webcast to Highlight TTX-MC138 Phase 2a Trial, Three-Platform Pipeline, and Investment Thesis BOSTON, June 8, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical-stage ...

NASA Goddard Space Flight Center's Dr. Jennifer Wiseman explains the Hubble Space Telescope's view of the Pillars of Creation ...

The HP EliteBoard G1a AI exists in a unique middle ground between a small-form-factor PC and a laptop. It is the result of ...

TransCode Therapeutics, Inc. a annoncé le lancement de son essai clinique de phase 2a. Cette étude vise à évaluer le principal candidat thérapeutique de la société, le TTX-MC138, chez ...

TransCode Therapeutics, Inc. a annoncé de nouveaux résultats concernant son essai clinique d'escalade de dose de phase 1a. L'étude a atteint son critère d'évaluation principal en matière ...

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. Its lead product candidate is TTX-MC138, an ...

Director C. Fitz reflects on the impact of the Black queer nightlife icon Jewel Thais-Williams, whose groundbreaking Los ...

Miri Technologies Inc. has begun shipping its highly anticipated V410 live 4K video encoder/decoder for streaming, IP-based production workflows and AV-over-IP distribution. Winner of a 2026 NAB Show ...

Senao SX906 PCIe card features up to 38 Intel Xeon cores and 64GB RAM ...